Literature DB >> 23222256

Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Mark W Hall1, Susan M Geyer, Chao-Yu Guo, Angela Panoskaltsis-Mortari, Philippe Jouvet, Jill Ferdinands, David K Shay, Jyotsna Nateri, Kristin Greathouse, Ryan Sullivan, Tram Tran, Shannon Keisling, Adrienne G Randolph.   

Abstract

OBJECTIVE: To prospectively evaluate relationships among serum cytokine levels, innate immune responsiveness, and mortality in a multicenter cohort of critically ill children with influenza infection.
DESIGN: Prospective, multicenter, observational study.
SETTING: Fifteen pediatric ICUs among members of the Pediatric Acute Lung Injury and Sepsis Investigators network. PATIENTS: Patients ≤18 yrs old admitted to a PICU with community-acquired influenza infection. A control group of outpatient children was also evaluated.
INTERVENTIONS: ICU patients underwent sampling within 72 hrs of ICU admission for measurement of a panel of 31 serum cytokine levels and quantification of whole blood ex vivo lipopolysaccharide-stimulated tumor necrosis factor-α production capacity using a standardized stimulation protocol. Outpatient control subjects also underwent measurement of tumor necrosis factor-α production capacity.
MEASUREMENTS AND MAIN RESULTS: Fifty-two patients (44 survivors, eight deaths) were sampled. High levels of serum cytokines (granulocyte macrophage colony-stimulating factor, interleukin-6, interleukin-8, interferon-inducible protein-10, monocyte chemotactic protein-1, and macrophage inflammatory protein-1α) were associated with mortality (p < 0.0016 for each comparison) as was the presence of secondary infection with Staphylococcus aureus (p = 0.007), particularly methicillin-resistant S. aureus (p < 0.0001). Nonsurvivors were immunosuppressed with leukopenia and markedly reduced tumor necrosis factor-α production capacity compared with outpatient control subjects (n = 21, p < 0.0001) and to ICU survivors (p < 0.0001). This association remained after controlling for multiple covariables. A tumor necrosis factor-α response <250 pg/mL was highly predictive of death and longer duration of ICU stay (p < 0.0001). Patients with S. aureus coinfection demonstrated the greatest degree of immunosuppression (p < 0.0001).
CONCLUSIONS: High serum levels of cytokines can coexist with marked innate immune suppression in children with critical influenza. Severe, early innate immune suppression is highly associated with both S. aureus coinfection and mortality in this population. Multicenter innate immune function testing is feasible and can identify these high-risk children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23222256      PMCID: PMC3705720          DOI: 10.1097/CCM.0b013e318267633c

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  54 in total

1.  Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle.

Authors:  W J Kox; R C Bone; D Krausch; W D Döcke; S N Kox; H Wauer; K Egerer; S Querner; K Asadullah; R von Baehr; H D Volk
Journal:  Arch Intern Med       Date:  1997-02-24

2.  IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner.

Authors:  Ido D Weiss; Ori Wald; Hanna Wald; Katia Beider; Michal Abraham; Eithan Galun; Arnon Nagler; Amnon Peled
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

3.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

Authors:  Christian Meisel; Joerg C Schefold; Rene Pschowski; Tycho Baumann; Katrin Hetzger; Jan Gregor; Steffen Weber-Carstens; Dietrich Hasper; Didier Keh; Heidrun Zuckermann; Petra Reinke; Hans-Dieter Volk
Journal:  Am J Respir Crit Care Med       Date:  2009-07-09       Impact factor: 21.405

4.  Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

Authors:  Cherrie-Lee Small; Christopher R Shaler; Sarah McCormick; Mangalakumari Jeyanathan; Daniela Damjanovic; Earl G Brown; Petra Arck; Manel Jordana; Charu Kaushic; Ali A Ashkar; Zhou Xing
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

5.  Immune dysregulation in severe influenza.

Authors:  Meredith L Heltzer; Susan E Coffin; Kelly Maurer; Asen Bagashev; Zhe Zhang; Jordan S Orange; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

6.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.

Authors:  Andrew Davies; Daryl Jones; Michael Bailey; John Beca; Rinaldo Bellomo; Nikki Blackwell; Paul Forrest; David Gattas; Emily Granger; Robert Herkes; Andrew Jackson; Shay McGuinness; Priya Nair; Vincent Pellegrino; Ville Pettilä; Brian Plunkett; Roger Pye; Paul Torzillo; Steve Webb; Michael Wilson; Marc Ziegenfuss
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

7.  Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina.

Authors:  Julio A Farias; Analía Fernández; Ezequiel Monteverde; Nilda Vidal; Pilar Arias; María J Montes; Gabriela Rodríguez; Mariela Allasia; Maria E Ratto; Roxana Jaén; Claudia Meregalli; Karina Fiquepron; Ana R Calvo; Alejandro Siaba; Lidia Albano; Rossana Poterala; Pablo Neira; Andrés Esteban
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

8.  Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

Authors:  Kelvin K W To; Ivan F N Hung; Iris W S Li; Kar-Lung Lee; Chi-Kwan Koo; Wing-Wa Yan; Raymond Liu; Ka-Ying Ho; Kwok-Hong Chu; Chi-Leung Watt; Wei-Kwang Luk; Kang-Yiu Lai; Fu-Loi Chow; Thomas Mok; Tom Buckley; Jasper F W Chan; Samson S Y Wong; Bojian Zheng; Honglin Chen; Candy C Y Lau; Herman Tse; Vincent C C Cheng; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2010-03-15       Impact factor: 9.079

9.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Raul Ortiz de Lejarazu; Tomas Pumarola; Jordi Rello; Raquel Almansa; Paula Ramírez; Ignacio Martin-Loeches; David Varillas; Maria C Gallegos; Carlos Serón; Dariela Micheloud; Jose Manuel Gomez; Alberto Tenorio-Abreu; María J Ramos; M Lourdes Molina; Samantha Huidobro; Elia Sanchez; Mónica Gordón; Victoria Fernández; Alberto Del Castillo; Ma Angeles Marcos; Beatriz Villanueva; Carlos Javier López; Mario Rodríguez-Domínguez; Juan-Carlos Galan; Rafael Cantón; Aurora Lietor; Silvia Rojo; Jose M Eiros; Carmen Hinojosa; Isabel Gonzalez; Nuria Torner; David Banner; Alberto Leon; Pablo Cuesta; Thomas Rowe; David J Kelvin
Journal:  Crit Care       Date:  2009-12-11       Impact factor: 9.097

10.  Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada.

Authors:  Darren H Freed; Dietrich Henzler; Chris W White; Robert Fowler; Ryan Zarychanski; Jamie Hutchison; Rakesh C Arora; Rizwan A Manji; Jean-Francois Legare; Tanya Drews; Stasa Veroukis; Murray Kesselman; Anne-Marie Guerguerian; Anand Kumar
Journal:  Can J Anaesth       Date:  2010-01-16       Impact factor: 5.063

View more
  75 in total

1.  Volatile Anesthetic Attenuates Phagocyte Function and Worsens Bacterial Loads in Wounds.

Authors:  Sophia Koutsogiannaki; Rachel Bernier; Kazumasa Tazawa; Koichi Yuki
Journal:  J Surg Res       Date:  2018-09-05       Impact factor: 2.192

2.  SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.

Authors:  E Kaitlynn Allen; Adrienne G Randolph; Tushar Bhangale; Pranay Dogra; Maikke Ohlson; Christine M Oshansky; Anthony E Zamora; John P Shannon; David Finkelstein; Amy Dressen; John DeVincenzo; Miguela Caniza; Ben Youngblood; Carrie M Rosenberger; Paul G Thomas
Journal:  Nat Med       Date:  2017-07-17       Impact factor: 53.440

3.  Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Authors:  Julie C Fitzgerald; Scott L Weiss; Shannon L Maude; David M Barrett; Simon F Lacey; J Joseph Melenhorst; Pamela Shaw; Robert A Berg; Carl H June; David L Porter; Noelle V Frey; Stephan A Grupp; David T Teachey
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 4.  Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis.

Authors:  Ben A Croker; John Silke; Motti Gerlic
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

5.  Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.

Authors:  Benjamin Lee; Keven M Robinson; Kevin J McHugh; Erich V Scheller; Sivanarayana Mandalapu; Chen Chen; Y Peter Di; Michelle E Clay; Richard I Enelow; Patricia J Dubin; John F Alcorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

Review 6.  Is the developmentally immature immune response in paediatric sepsis a recapitulation of immune tolerance?

Authors:  Aline B Maddux; Ivor S Douglas
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

7.  Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.

Authors:  Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski
Journal:  Blood Adv       Date:  2018-09-25

8.  Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).

Authors:  Martin Albert; David Williamson; John Muscedere; Francois Lauzier; Coleman Rotstein; Salmaan Kanji; Xuran Jiang; Mark Hall; Daren Heyland
Journal:  Intensive Care Med       Date:  2014-07-01       Impact factor: 17.440

Review 9.  Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Authors:  Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

Review 10.  Immunoparalysis in Pediatric Critical Care.

Authors:  Mark W Hall; Kristin C Greathouse; Rajan K Thakkar; Eric A Sribnick; Jennifer A Muszynski
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.